{"id":28436,"date":"2026-04-17T04:50:30","date_gmt":"2026-04-17T11:50:30","guid":{"rendered":"https:\/\/magventure.com\/us\/?p=28436"},"modified":"2026-04-17T05:20:43","modified_gmt":"2026-04-17T12:20:43","slug":"new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression","status":"publish","type":"post","link":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/","title":{"rendered":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression"},"content":{"rendered":"
\n
\n
\n
\n
\n \n \n News\n<\/p>\n <\/div>\n

April 17th 2026<\/p>\n <\/div>\n

New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression<\/h1>\n <\/div>\n
\n \"New\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n
\n

<\/p>\n\n\n\n

<\/h2>\n\n\n\n

Farum, Denmark \u2013 April 17, 2026<\/strong><\/p>\n\n\n\n

MagVenture, a global provider of non-invasive neuromodulation solutions, today marks the publication of a landmark randomized clinical trial evaluating Magnetic Seizure Therapy (MST) for the treatment of Major Depressive Disorder (MDD) in The Lancet Psychiatry<\/em>.<\/strong><\/p>\n\n\n\n

This milestone represents an important moment for both MagVenture and the broader field of brain stimulation, as the largest Magnetic Seizure Therapy study to date is now available in one of the world\u2019s most prestigious medical journals.<\/p>\n\n\n\n

The Canada- and U.S.-based multicenter trial, Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST\u2013MST): a randomised, double-blind, non-inferiority trial in Canada and the USA, included 236 participants, making it the most comprehensive MST study conducted to date.<\/p>\n\n\n\n

The Phase III study also represents the largest clinical research investment in MagVenture\u2019s history, reflecting the company\u2019s long-term commitment to advancing innovation in convulsive therapies.<\/p>\n\n\n\n

Results from the randomized, double-blind, non-inferiority trial demonstrated that MST achieved non-inferior efficacy compared to right unilateral ultra-brief pulse-width electroconvulsive therapy (RUL-UB ECT) in achieving remission of depressive symptoms. At the same time, MST showed a more favorable cognitive safety profile, with substantially fewer patients experiencing clinically meaningful worsening in autobiographical memory.<\/strong><\/p>\n\n\n\n

Additional findings demonstrated comparable response and remission rates across key depression endpoints, similar improvements in suicidality outcomes, time to reorientation, and an overall favorable tolerability profile, with the majority of the reported adverse events classified as mild.<\/p>\n\n\n\n

\n
Read the full study here<\/a><\/div>\n<\/div>\n\n\n\n

MST is an emerging form of convulsive therapy that has been investigated for its potential antidepressant effects by inducing a therapeutic seizure. However, MST differs from ECT as it uses a magnetic field to induce a therapeutic seizure<\/strong>. This approach enables more focal brain activation and has been associated with reduced cognitive adverse effects across multiple domains, including memory, attention, and executive function.<\/p>\n\n\n\n

The CREST-MST study was conducted using MagVenture\u2019s proprietary MST technology, including the MagPro XP Black\u2122 magnetic stimulator and the MagVenture TwinCoil\u2122, designed to enable powerful, consistent and controlled delivery of therapeutic stimulation.<\/p>\n\n\n\n

The study reflects more than eight years of dedicated research since its initiation in 2018. MagVenture supported the trial by providing MST systems and backup devices across all participating sites, contributing to the successful execution of this large-scale investigation. MagVenture has been engaged in MST research since the early 2000s and remains among the first manufacturers actively developing this technology.<\/p>\n\n\n\n

\u201cWe are highly encouraged by the publication of this important study in prestigious The Lancet Psychiatry,\u201d<\/em> said Christian Wanding, CCO of MagVenture A\/S. \u201cMagVenture has been deeply involved in the development of MST for more than two decades, and this study represents a significant milestone not only for our organization but for the field as a whole. Supporting this level of rigorous clinical research reflects our long-standing commitment to advancing new treatment modalities that can meaningfully improve patient outcomes, particularly in areas where unmet needs remain high.\u201d<\/em><\/p>\n\n\n\n

\u201cThis study marks a turning point in the evolution of convulsive therapies. MST has the potential to transform how we treat severe depression by preserving the therapeutic benefits of ECT while significantly improving the patient experience, particularly in terms of cognitive outcomes.\u201d<\/strong><\/em>  says Dr. Daniel Blumberger, Senior Scientist at CAMH and co-lead of the study. <\/strong><\/p>\n\n\n\n

“A key barrier to ECT adoption has been concern about cognitive side effects. MST offers comparable efficacy to ECT without cognitive side effects, which may broaden acceptance of convulsive therapies for patients who need it most.<\/strong><\/em>“ Said Dr. Zafiris Daskalakis, Professor and Chair of the Department of Psychiatry and Dr. Igor and JoAnn Grant Endowed Chair at UC San Diego School of Medicine<\/strong><\/p>\n\n\n\n

The results also highlight MST\u2019s potential role in addressing a significant unmet need in depression care, as many patients decline ECT despite its established efficacy due to concerns about cognitive side effects. The CREST-MST findings support MST as a compelling future therapeutic alternative within convulsive therapies, offering a differentiated balance of efficacy and tolerability.<\/p>\n\n\n\n

MagVenture is actively pursuing regulatory clearance of MST in multiple markets <\/strong>worldwide and continues to support additional research initiatives across Canada, the United States, Brazil, China, Japan, and Europe, reflecting sustained global interest in this emerging therapeutic approach.t clinicians in improving patient outcomes across a range of neurological and psychiatric conditions.<\/p>\n\n\n\n

<\/p>\n\n\n\n

MagVenture Magnetic Seizure Therapy (MST) Systems are not approved or cleared for clinical use in any market worldwide. CAUTION, INVESTIGATIONAL DEVICE. The MagVenture MST System is limited by Federal (or United States) law to investigational use.<\/em><\/p>\n\n\n\n

Contact:<\/p>\n\n\n\n

Lilja Gudmundsdottir Astrup, MST Program Lead, MagVenture A\/S
\ud83d\udce7 lga@magventure.com<\/a>
\ud83d\udcde +45 42 92 46 06<\/p>\n<\/div><\/div><\/section>\n\n\n\n

Share article<\/p>

<\/path><\/g><\/rect><\/clipPath><\/defs><\/svg><\/a><\/path><\/g><\/rect><\/clipPath><\/defs><\/svg><\/a><\/path><\/g><\/rect><\/clipPath><\/defs><\/svg><\/a><\/div><\/div><\/div><\/section>\n\n\n\n\n
<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":15,"featured_media":28437,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[82],"tags":[134,135,129,132,136,125,133,126,128,127,131,130],"class_list":["post-28436","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-brain-stimulation-research","tag-cognitive-safety-profile","tag-convulsive-therapy","tag-ect-comparison","tag-investigational-medical-deviice","tag-magnetic-seizure-therapy","tag-magventure-mst","tag-major-depressive-disorder-research","tag-mst-depression-trial","tag-neuromodulation","tag-randomized-clinical-trial","tag-the-lancet-psychiatry"],"acf":[],"yoast_head":"\nNew Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US<\/title>\n<meta name=\"description\" content=\"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US\" \/>\n<meta property=\"og:description\" content=\"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/\" \/>\n<meta property=\"og:site_name\" content=\"MagVenture US\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-17T11:50:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T12:20:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"825\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Leonardo Rodovero\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Leonardo Rodovero\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/\"},\"author\":{\"name\":\"Leonardo Rodovero\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/#\\\/schema\\\/person\\\/49075fc3a9a19590e0c64ce56421f9aa\"},\"headline\":\"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression\",\"datePublished\":\"2026-04-17T11:50:30+00:00\",\"dateModified\":\"2026-04-17T12:20:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/\"},\"wordCount\":782,\"image\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magventure.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/04\\\/MST-Press-Release-low-res-scaled-1024x825-1.jpg\",\"keywords\":[\"brain stimulation research\",\"cognitive safety profile\",\"convulsive therapy\",\"ECT comparison\",\"investigational medical deviice\",\"Magnetic Seizure Therapy\",\"MagVenture MST\",\"major depressive disorder research\",\"MST depression trial\",\"neuromodulation\",\"randomized clinical trial\",\"The Lancet Psychiatry\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/\",\"url\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/\",\"name\":\"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/magventure.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/04\\\/MST-Press-Release-low-res-scaled-1024x825-1.jpg\",\"datePublished\":\"2026-04-17T11:50:30+00:00\",\"dateModified\":\"2026-04-17T12:20:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/#\\\/schema\\\/person\\\/49075fc3a9a19590e0c64ce56421f9aa\"},\"description\":\"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#primaryimage\",\"url\":\"https:\\\/\\\/magventure.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/04\\\/MST-Press-Release-low-res-scaled-1024x825-1.jpg\",\"contentUrl\":\"https:\\\/\\\/magventure.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/04\\\/MST-Press-Release-low-res-scaled-1024x825-1.jpg\",\"width\":1024,\"height\":825},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/magventure.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/magventure.com\\\/us\\\/\",\"name\":\"MagVenture US\",\"description\":\"We are unlocking the science of magnetic stimulation for treatment of depression\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/magventure.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/magventure.com\\\/us\\\/#\\\/schema\\\/person\\\/49075fc3a9a19590e0c64ce56421f9aa\",\"name\":\"Leonardo Rodovero\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g\",\"caption\":\"Leonardo Rodovero\"},\"url\":\"https:\\\/\\\/magventure.com\\\/us\\\/author\\\/leonardo\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US","description":"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/","og_locale":"en_US","og_type":"article","og_title":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US","og_description":"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.","og_url":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/","og_site_name":"MagVenture US","article_published_time":"2026-04-17T11:50:30+00:00","article_modified_time":"2026-04-17T12:20:43+00:00","og_image":[{"width":1024,"height":825,"url":"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg","type":"image\/jpeg"}],"author":"Leonardo Rodovero","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Leonardo Rodovero","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#article","isPartOf":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/"},"author":{"name":"Leonardo Rodovero","@id":"https:\/\/magventure.com\/us\/#\/schema\/person\/49075fc3a9a19590e0c64ce56421f9aa"},"headline":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression","datePublished":"2026-04-17T11:50:30+00:00","dateModified":"2026-04-17T12:20:43+00:00","mainEntityOfPage":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/"},"wordCount":782,"image":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#primaryimage"},"thumbnailUrl":"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg","keywords":["brain stimulation research","cognitive safety profile","convulsive therapy","ECT comparison","investigational medical deviice","Magnetic Seizure Therapy","MagVenture MST","major depressive disorder research","MST depression trial","neuromodulation","randomized clinical trial","The Lancet Psychiatry"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/","url":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/","name":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression - MagVenture US","isPartOf":{"@id":"https:\/\/magventure.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#primaryimage"},"image":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#primaryimage"},"thumbnailUrl":"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg","datePublished":"2026-04-17T11:50:30+00:00","dateModified":"2026-04-17T12:20:43+00:00","author":{"@id":"https:\/\/magventure.com\/us\/#\/schema\/person\/49075fc3a9a19590e0c64ce56421f9aa"},"description":"MagVenture highlights a Phase III randomized trial of Magnetic Seizure Therapy (MST) for major depressive disorder, published in The Lancet Psychiatry, showing non-inferior efficacy to ECT with a differentiated cognitive safety profile.","breadcrumb":{"@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#primaryimage","url":"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg","contentUrl":"https:\/\/magventure.com\/us\/wp-content\/uploads\/sites\/6\/2026\/04\/MST-Press-Release-low-res-scaled-1024x825-1.jpg","width":1024,"height":825},{"@type":"BreadcrumbList","@id":"https:\/\/magventure.com\/us\/new-lancet-psychiatry-publication-reports-results-from-large-randomized-trial-of-magnetic-seizure-therapy-in-depression\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/magventure.com\/us\/"},{"@type":"ListItem","position":2,"name":"New Lancet Psychiatry Publication Reports Results from Large Randomized Trial of Magnetic Seizure Therapy in Depression"}]},{"@type":"WebSite","@id":"https:\/\/magventure.com\/us\/#website","url":"https:\/\/magventure.com\/us\/","name":"MagVenture US","description":"We are unlocking the science of magnetic stimulation for treatment of depression","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/magventure.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/magventure.com\/us\/#\/schema\/person\/49075fc3a9a19590e0c64ce56421f9aa","name":"Leonardo Rodovero","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7565d3f6d7aa5af78facf8eca0e1e237f75de99ada7d9c8ef7929dcdb4045ba1?s=96&d=mm&r=g","caption":"Leonardo Rodovero"},"url":"https:\/\/magventure.com\/us\/author\/leonardo\/"}]}},"_links":{"self":[{"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/posts\/28436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/comments?post=28436"}],"version-history":[{"count":2,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/posts\/28436\/revisions"}],"predecessor-version":[{"id":28439,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/posts\/28436\/revisions\/28439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/media\/28437"}],"wp:attachment":[{"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/media?parent=28436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/categories?post=28436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/magventure.com\/us\/wp-json\/wp\/v2\/tags?post=28436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}